Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus

Journal of Clinical Microbiology

Volumn 44, Issue 5, 2006, Pages 1877-1880

  Jouvencel, Anne Christine ^a   Neau, Didier ^b   Faure, Muriel ^a   Neau, Martine ^b   Martinaud, Christophe ^a   Legrand, Elisabeth ^a   Trimoulet, Pascale ^a   Garrigue, Isabelle ^a   Le Bail, Brigitte ^b   Bioulac Sage, Paulette ^b   Dupon, Michel ^b   Ragnaud, Jean Marie ^b   Fleury, Herve ^a   Lafon, Marie Edith ^a  

^a University Victor Segalen   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

CASE-CONTROL STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERONS; LIVER; ORGAN SPECIFICITY; VARIATION (GENETICS); VIREMIA;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33646549891     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.5.1877-1880.2006     Document Type: Article

References (25)

1. Alfonso, V., D. M. Flichman, S. Sookoian, V. A. Mbayed, and R. H. Campos. 2004. Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection. J. Gen. Virol. 85:39-46.
2. Babik, J. M., and M. Holodniy. 2003. Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients. J. Virol. 77:1940-1950.
3. Cabot, B., M. Martell, J. I. Esteban, S. Sauleda, T. Otero, R. Esteban, J. Guardia, and J. Gomez. 2000. Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J. Virol. 74:805-811.
4. Cribier, B., C. Schmitt, D. Rey, G. Uhl, J. M. Lang, D. Vetter, A. Kirn, and F. Stoll-Keller. 1997. HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype. Res. Virol. 148:267-271.
5. Farci, P., A. Shimoda, A. Coiana, G. Diaz, G. Peddis, J. C. Melpolder, A. Strazzera, D. Y. Chien, S. J. Munoz, A. Balestrieri, R. H. Purcell, and H. J. Alter. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344.
6. Gretch, D. R., S. J. Polyak, J. J. Wilson, R. L. Carithers, Jr., J. D. Perkins, and L. Corey. 1996. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J. Virol. 70:7622-7631.
7. Hino, K., Y. Yamaguchi, D. Fujiwara, Y. Katoh, M. Korenaga, M. Okazaki, M. Okuda, and K. Okita. 2000. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study. J. Viral Hepat. 7:36-42.
8. Le Guen, B., G. Squadrito, B. Nalpas, P. Berthelot, S. Pol, and C. Brechot. 1997. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 25:1250-1254.
9. Martell, M., J. I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, J. Guardia, and J. Gomez. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66:3225-3229.
10. Mizokami, M., T. Ohno, K. Ohba, G. L. Davis, K. Suzuki, E. Orito, and J. Y. Lau. 1999. Interferon-alpha therapy exerts selective pressure on hepatitis C virus quasispecies equilibrium. Antivir. Ther. 4:15-19.
11. Neau, D., A. C. Jouvencel, E. Legrand, P. Trimoulet, T. Galperine, I. Chitty, M. Ventura, B. Le Bail, P. Morlat, J. Y. Lacut, J. M. Ragnaud, M. Dupon, H. Fleury, and M. E. Lafon. 2003. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients. J. Med. Virol. 71:41-48.
12. Okuda, M., K. Hino, M. Korenaga, Y. Yamaguchi, Y. Katoh, and K. Okita. 1999. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology 29:217-222.
13. Pawlotsky, J. M., G. Germanidis, P. O. Frainais, M. Bouvier, A. Soulier, M. Pellerin, and D. Dhumeaux. 1999. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J. Virol. 73:6490-6499.
14. Pawlotsky, J. M., M. Pellerin, M. Bouvier, F. Roudot-Thoraval, G. Germanidis, A. Bastie, F. Darthuy, J. Remire, C. J. Soussy, and D. Dhumeaux. 1998. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J. Med. Virol. 54:256-264.
15. Roque-Afonso, A. M., M. Robain, D. Simoneau, P. Rodriguez-Mathieu, M. Gigou, L. Meyer, and E. Dussaix. 2002. Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus. J. Infect. Dis. 185:728-733.
16. Sakai, A., S. Kaneko, M. Honda, E. Matsushita, and K. Kobayashi. 1999. Quasispecies of hepatitis C virus in serum and in three different parts of the liver of patients with chronic hepatitis. Hepatology 30:556-561.
17. Sandres, K., M. Dubois, C. Pasquier, J. L. Payen, L. Alric, M. Duffaut, J. P. Vinel, J. P. Pascal, J. Puel, and J. Izopet. 2000. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy. J. Virol. 74:661-668.
18. Seibert, S. A., C. Y. Howell, M. K. Hughes, and A. L. Hughes. 1995. Natural selection on the gag, pol, and env genes of human immunodeficiency virus 1 (HIV-1). Mol. Biol. Evol. 12:803-813.
19. Sherman, K. E., C. Andreatta, J. O'Brien, A. Gutierrez, and R. Harris. 1996. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 23:688-694.
20. Soto, B., A. Sanchez-Quijano, L. Rodrigo, J. A. del Olmo, M. Garcia-Bengoechea, J. Hernandez-Quero, C. Rey, M. A. Abad, M. Rodriguez, M. Sales Gilabert, F. Gonzalez, P. Miron, A. Caruz, F. Relimpio, R. Torronteras, M. Leal, and E. Lissen. 1997. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J. Hepatol. 26:1-5.
21. Steinhauer, D. A., E. Domingo, and J. J. Holland. 1992. Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene 122:281-288.
22. Trimoulet, P., D. Neau, B. Le Bail, A. Rullier, M. Winnock, T. Galperine, E. Legrand, E. Schvoerer, M. Dupon, J. M. Ragnaud, P. Bioulac-Sage, G. Chene, H. Fleury, and M. E. Lafon. 2002. Intrahepatic HCV RNA loads in 37 HIV-HCV coinfected patients with controlled HIV infection. J. Med. Virol. 67:143-151.
23. Weiner, A. J., H. M. Geysen, C. Christopherson, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, et al. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89:3468-3472.
24. Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, and J. T. Safrit. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
25. Zylberberg, H., and S. Pol. 1996. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin. Infect. Dis. 23:1117-1125.